Introduction: Protein energy wasting is closely related to increased morbidity and mortality in peritoneal dialysis (PD) patients. Simple reliable and easily available methods of determining nutritional status and recognition of short-term changes in body composition are therefore important for clinical practice. Methods: We compared whole-body and segmental composition using multifrequency bioelectrical impedance analysis (MF-BIA) and dual-energy X-ray absorptiometry (DEXA) in 104 stable PD patients. Results: Assessment of whole-body composition showed that lean body mass (LBM) was highly correlated with good method agreement using DEXA as the reference test (r = 0.95, p < 0.0001; bias –0.88 kg, 95% CI –1.53 to 0.23 kg). Similarly, high correlation and good method agreement were found for fat mass (r = 0.93, p < 0.0001; bias 0.69 kg, 95% CI 0.03–1.36 kg). Segmental analysis of LBM revealed strong correlations between LBM for trunk, left and right arms and legs (r = 0.90, 0.84, 0.86, 0.89 and 0.90, respectively, p < 0.0001). Bone mineral content derived by MF-BIA overestimated that measured by DEXA (bias 0.740 kg, 95% CI 0.66–0.82 kg). Conclusion: MF-BIA may potentially be a useful tool for determining nutritional status in PD patients and serial estimations may help recognize short-term changes in body composition.

1.
K/DOQI, National Kidney Foundation: Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35(suppl 2):S1–S140.
2.
Prasad N, Gupta A, Sinha A, Sharma RK, Saxena A, Kaul A, Bhaduria D, Gupta A: Confounding effect of comorbidities and malnutrition on survival of peritoneal dialysis patients. J Ren Nutr 2010;20:384–391.
3.
Bhatla B, Moore H, Emerson P, Keshaviah P, Prowant B, Nolph KD, Singh A: Lean body mass estimation by creatinine kinetics, bioimpedance, and dual energy x-ray absorptiometry in patients on continuous ambulatory peritoneal dialysis. ASAIO J 1995;41:M442–M446.
4.
Bishop CW, Bowen PE, Ritchey SJ: Norms for nutritional assessment of American adults by upper arm anthropometry. Am J Clin Nutr 1981;34:2530–2539.
5.
Morey B, Walker R, Davenport A: More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract 2008;109:c173–c180.
6.
Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77–97.
7.
Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27–39.
8.
Hume R, Weyers E: Relationship between total body water and surface area in normal and obese subjects. J Clin Pathol 1971;24:234–238.
9.
McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Chuchill DN, for the Canada-USA (CANUSA) Peritoneal Dialysis Study Group: How much peritoneal dialysis is required for the maintenance of good nutritional state? Kidney Int 1996;50(suppl 56):S56–S61.
10.
Essig M, Vrtovsnik F: How to evaluate body composition in chronic kidney disease? Nephrol Ther 2008;4:92–98.
11.
Locatelli F, Fouque D, Heimburger O, Drüeke TB, Cannata-Andía JB, Hörl WH, Ritz E: Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant 2002;17:563–572.
12.
Thomas EL, Frost G, Harrington T, Bell JD: Validation on ‘in-body’ bioelectrical impedance by whole-body MRI. Laboratory Report, 2001.
13.
Davenport A, Willicombe MK: Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multifrequency bioimpedance. Int J Artif Organs 2009;32:779–786.
14.
Davenport A, Willicombe MK: Hydration status does not influence peritoneal equilibration test ultrafiltration volumes. Clin J Am Soc Nephrol 2009;4:1207–1212.
15.
Bedogni G, Malavolti M, Severi S, Poli M, Mussi C, Fantuzzi AL, Battistini N: Accuracy of an 8-point tactile-electrode impedance method in the assessment of total body water. Eur J Clin Nutr 2002;56:1143–1148.
16.
Fürstenberg A, Davenport A: Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient haemodialysis patients. Am J Kidney Dis 2011;57:123–129.
17.
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–310.
18.
Davies S: Renal Association Clinical Guidelines. Module 6: Peritoneal Dialysis. http://www.renal.org/Clinical/GuidelinesSection/Guidelines.aspx (accessed November 2010).
19.
Ho LC, Wang HH, Chiang CK, Hung KY, Wu KD: Malnutrition-inflammation score independently determined cardiovascular and infection risk in peritoneal dialysis patients. Blood Purif 2010;29:308–316.
20.
Negri AL, Barone R, Veron D, Fraga A, Arrizurieta E, Zucchini A, Zanchetta JR: Lean mass estimation by creatinine kinetics and dual-energy x-ray absorptiometry in peritoneal dialysis. Nephron Clin Pract 2003;95:c9–c14.
21.
Davenport A, Willicombe MK: Does diabetes mellitus predispose to increased fluid overload in peritoneal dialysis patients? Nephron Clin Pract 2009;114:c60–c66.
22.
Mendley SR, Majkowski NL, Schoeller DA: Validation of estimates of total body water in pediatric dialysis patients by deuterium dilution. Kidney Int 2005;67:2056–2062.
23.
Konings CJ, Kooman JP, Schonck M, Cox-Reijven PL, van Kreel B, Gladziwa U, Wirtz J, Gerlag PG, Hoorntje SJ, Wolters J, Heidendal GA, van der Sande FM, Leunissen KM: Assessment of fluid status in peritoneal dialysis patients. Perit Dial Int 2002;22:683–692.
24.
Konings CJ, Kooman JP, Schonck M, van Kreel B, Heidendal GA, Cheriex EC, van der Sande FM, Leunissen KM: Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients. Perit Dial Int 2003;23:184–190.
25.
Van de Kerkhof J, Konings CJ, van Kreel B, van der Sande FM, Leunissen KM, Kooman JP: Bioimpedance analysis and assessment of intracellular water in peritoneal dialysis patients. Perit Dial Int 2003;23:591–593.
26.
Genton L, Karsegard VL, Zawadynski S, Kyle UG, Pichard C, Golay A, Hans DB: Comparison of body weight and composition measured by two different dual-energy X-ray absorptiometry devices and three acquisition modes in obese women. Clin Nutr 2006;25:428–437.
27.
Schoeller DA, Tylavsky FA, Baer DJ, Chumlea WC, Earthman CP, Fuerst T, Harris TB, Heymsfield SB, Horlick M, Lohman TG, Lukaski HC, Shepherd J, Siervogel RM, Borrud LG: QDR 4500A dual-energy X-ray absorptiometer underestimates fat mass in comparison with criterion methods in adults. Am J Clin Nutr 2005;81:1018–1025.
28.
Foster KR, Lukask HC: Whole-body impedance – what does it measure? Am J Clin Nutr 1996;64(suppl 3):S388–S396.
29.
Lim S, Joung H, Chin CS, Lee HK, Kim KS, Shin EK, Kim HY, Lim MK, Cho SI: Body composition changes with age have gender-specific impacts on bone mineral density. Bone 2004;35:792–798.
30.
Chan TM, Pun KK, Cheng IK: Total and regional bone densities in dialysis patients. Nephrol Dial Transplant 1992;7:835–839.
31.
Johnson DW, McIntyre HD, Brown A, Freeman J, Rigby RJ: The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1996;16:34–40.
32.
Woodrow G, Devine Y, Cullen M, Lindley E: Application of bioelectrical impedance to clinical assessment of body composition in peritoneal dialysis. Perit Dial Int 2007;27:496–502.
33.
Lee SW, Song JH, Kim GA, Lee KL, Kim MJ: Assessment of total body water for anthropometry-based equations using bioimpedance as reference in Korean adult controls and haemodialysis subjects. Nephrol Dial Transplant 2001;16:91–97.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.